Home › Research › Costs and economics
Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses
Lee NR, Tao S, Voltaire S, Bishop L, Esbensen A, Lee B, Shea L, Wallace G.. PsyArXiv, 2026-06-15
Topic: Brain imaging, connectivity and assessment
Plain-language summary
Higher prevalence was observed in the ID group relative to the general population for epilepsy, young-onset ADRD, and their comorbidity. Among participants with ID, ASD was associated with the greatest epilepsy risk whereas DS was associated with the greatest risk for ADRD and epilepsy+ADRD. When DS and ASD diagnoses were considered together, interactions were observed, indicating subtle differences in the risk for these conditions among participants with both DS and ASD. These results support the importance of screening adults with ID for epilepsy and young-onset dementia. They also draw attention to subgroups of people with ID who may be at greater risk for these conditions, and the importance of evaluating the co-occurrence of these conditions among adults with ID.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lee, N. R., Tao, S., Voltaire, S., Bishop, L., Esbensen, A., Lee, B., et al. (2026). Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses. PsyArXiv. https://doi.org/10.31234/osf.io/647m3_v2
Vancouver
Lee NR, Tao S, Voltaire S, Bishop L, Esbensen A, Lee B, et al. Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses. PsyArXiv. 2026. doi:10.31234/osf.io/647m3_v2.
BibTeX
@article{lee2026-1135530e,
author = {Lee, N. R. and Tao, S. and Voltaire, S. and Bishop, L. and Esbensen, A. and Lee, B. and Shea, L. and Wallace, G.},
title = {{Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses}},
journal = {PsyArXiv},
year = {2026},
doi = {10.31234/osf.io/647m3_v2},
url = {https://doi.org/10.31234/osf.io/647m3_v2}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Higher prevalence was observed in the ID group relative to the general population for epilepsy, young-onset ADRD, and their comorbidity.
- Among participants with ID, ASD was associated with the greatest epilepsy risk whereas DS was associated with the greatest risk for ADRD and epilepsy+ADRD.
- When DS and ASD diagnoses were considered together, interactions were observed, indicating subtle differences in the risk for these conditions among participants with both DS and ASD.
- These results support the importance of screening adults with ID for epilepsy and young-onset dementia.
- They also draw attention to subgroups of people with ID who may be at greater risk for these conditions, and the importance of evaluating the co-occurrence of these conditions among adults with ID.
New to this subject? Start with our plain-English guide: Costs & economics →
Study details
- Study designcross-sectional
- Participants847,430
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 39 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 24 of the 62 points we could judge it on, which is 39 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (PsyArXiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 4 / 4 | 847,430 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 24 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 24 of the 62 points we could judge it on is 39 out of 100. |
| Total | 39 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Costs and economics from nearby years
Also tagged “dosage”
80 studies in the library carry the topic tag “dosage”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 80 tagged studies.